U.S. Pharmaceutical Sales - Q4 2012
The following is a list of the top 100 prescribed medicines by U.S. National Sales in Q4 2012. Figures include sales through both retail and hospital channels, listed by drug name and sales value in U.S. dollars.
Last updated: February 2014 (updated quarterly).
Top 100 drugs for Q4 2012 by sales
- Sales Statistics Q4 2012
- Units*
Rank |
Drug |
Sales ($000) |
|
|
1 ( 1) |
Abilify Otsuka Pharmaceutical Co., Ltd |
1,478,301 |
5.20% |
Stats |
2 ( 1) |
Nexium AstraZeneca |
1,441,472 |
1.45% |
Stats |
3 |
Crestor AstraZeneca |
1,275,483 |
2.41% |
Stats |
4 |
Cymbalta
|
1,227,484 |
5.97% |
Stats |
5 |
Humira AbbVie Inc. |
1,206,377 |
4.70% |
Stats |
6 |
Advair Diskus GlaxoSmithKline |
1,204,874 |
4.90% |
Stats |
7 |
Enbrel Amgen Inc. |
1,088,533 |
2.05% |
Stats |
8 |
Remicade Janssen Pharmaceuticals, Inc. |
935,584 |
-1.73% |
Stats |
9 |
Copaxone Teva Pharmaceuticals USA, Inc. |
908,061 |
3.47% |
Stats |
10 |
Neulasta Amgen Inc. |
803,286 |
-3.54% |
Stats |
11 |
Rituxan Genentech, Inc. |
779,026 |
0.72% |
Stats |
12 ( 2) |
Spiriva Boehringer Ingelheim Pharmaceuticals, Inc. |
702,246 |
4.83% |
Stats |
13 ( 1) |
Atripla Gilead Sciences, Inc. |
695,411 |
0.46% |
Stats |
14 ( 1) |
OxyContin Purdue Pharma LP |
668,415 |
-1.69% |
Stats |
15 |
Januvia Merck |
658,957 |
1.18% |
Stats |
16 |
Avastin Genentech, Inc. |
634,201 |
-2.49% |
Stats |
17 |
Lantus Sanofi |
599,359 |
7.77% |
Stats |
18 ( 1) |
Lantus Solostar Sanofi |
597,688 |
11.58% |
Stats |
19 ( 1) |
Truvada Gilead Sciences, Inc. |
565,853 |
2.64% |
Stats |
20 |
Epogen Amgen Inc. |
514,165 |
-2.27% |
Stats |
21 |
Lyrica
|
511,571 |
2.36% |
Stats |
22 |
Celebrex
|
505,850 |
2.61% |
Stats |
23 ( 1) |
Diovan Novartis Pharmaceuticals Corporation |
474,603 |
1.13% |
Stats |
24 ( 2) |
Herceptin Genentech, Inc. |
464,737 |
3.22% |
Stats |
25 ( 2) |
Namenda Allergan plc |
454,671 |
5.09% |
Stats |
26 ( 1) |
Gleevec Novartis Pharmaceuticals Corporation |
436,298 |
-4.10% |
Stats |
27 ( 1) |
Suboxone
|
417,264 |
6.18% |
Stats |
28 ( 7) |
Vyvanse Takeda Pharmaceutical Company Limited |
408,526 |
11.92% |
Stats |
29 ( 9) |
methylphenidate Generic |
399,702 |
15.21% |
Stats |
30 ( 1) |
Lucentis Genentech, Inc. |
395,931 |
3.63% |
Stats |
31 ( 1) |
enoxaparin Generic |
394,149 |
1.54% |
Stats |
32 ( 4) |
Zetia Merck |
375,281 |
4.04% |
Stats |
33 ( 4) |
Avonex Biogen |
371,884 |
-5.17% |
Stats |
34 ( 1) |
OneTouch
|
349,860 |
-6.59% |
Stats |
35 ( 5) |
Lidoderm Endo Pharmaceuticals Inc. |
348,610 |
6.67% |
Stats |
36 ( 1) |
AndroGel AbbVie Inc. |
346,491 |
-0.34% |
Stats |
37 ( 6) |
Symbicort AstraZeneca |
340,401 |
10.64% |
Stats |
38 ( 4) |
Rebif EMD Serono, Inc. |
311,851 |
1.13% |
Stats |
39 ( 5) |
Novolog Novo Nordisk |
311,150 |
5.87% |
Stats |
40 ( 9) |
Levemir Novo Nordisk |
308,726 |
12.31% |
Stats |
41 ( 6) |
Alimta Eli Lilly and Company |
298,106 |
7.89% |
Stats |
42 ( 9) |
NovoLog FlexPen Novo Nordisk |
293,569 |
8.43% |
Stats |
43 ( 5) |
Viagra
|
290,880 |
5.36% |
Stats |
44 ( 2) |
Seroquel XR AstraZeneca |
284,989 |
0.24% |
Stats |
45 ( 7) |
ProAir HFA Teva Pharmaceuticals USA, Inc. |
284,649 |
6.33% |
Stats |
46 ( ) |
Synagis MedImmune, Inc. |
281,760 |
n/a |
Stats |
47 ( 15) |
Flovent HFA GlaxoSmithKline |
268,626 |
13.24% |
Stats |
48 ( 8) |
Niaspan AbbVie Inc. |
268,151 |
2.01% |
Stats |
49 ( 1) |
amphetamine/dextroamphetamine Generic |
267,476 |
-1.85% |
Stats |
50 ( 5) |
Incivek Vertex Pharmaceuticals Incorporated |
266,240 |
-9.14% |
Stats |
51 ( 2) |
Lovaza GlaxoSmithKline |
266,067 |
-0.19% |
Stats |
52 ( 37) |
budesonide Generic |
265,773 |
42.52% |
Stats |
53 ( 1) |
Combivent Boehringer Ingelheim Pharmaceuticals, Inc. |
265,042 |
-0.14% |
Stats |
54 ( 12) |
modafinil Generic |
264,781 |
15.91% |
Stats |
55 ( 6) |
Nasonex Merck |
260,739 |
5.44% |
Stats |
56 ( 2) |
Humalog Eli Lilly and Company |
257,939 |
2.61% |
Stats |
57 ( 12) |
acetaminophen/hydrocodone Generic |
248,050 |
9.57% |
Stats |
58 ( 1) |
Procrit Janssen Pharmaceuticals, Inc. |
246,708 |
-6.07% |
Stats |
59 |
metoprolol Generic |
239,668 |
-4.04% |
Stats |
60 ( 4) |
Isentress Merck |
238,849 |
2.34% |
Stats |
61 ( ) |
valsartan Generic |
237,796 |
n/a |
Stats |
62 ( 1) |
Reyataz Bristol-Myers Squibb Company |
237,659 |
0.65% |
Stats |
63 ( 5) |
Cialis Eli Lilly and Company |
237,294 |
4.79% |
Stats |
64 ( ) |
Tamiflu
|
237,097 |
n/a |
Stats |
65 ( 7) |
Restasis Allergan plc |
233,071 |
7.36% |
Stats |
66 ( 4) |
Gilenya Novartis Pharmaceuticals Corporation |
232,746 |
5.17% |
Stats |
67 ( 7) |
Neupogen Amgen Inc. |
231,017 |
-7.01% |
Stats |
68 ( 6) |
Victoza Novo Nordisk |
227,520 |
8.78% |
Stats |
69 ( 2) |
Janumet Merck |
222,968 |
-2.34% |
Stats |
70 ( 14) |
Zostavax Merck |
222,633 |
14.39% |
Stats |
71 ( 6) |
Vytorin Merck |
221,891 |
-3.06% |
Stats |
72 ( 11) |
Prezista Janssen Pharmaceuticals, Inc. |
216,609 |
10.09% |
Stats |
73 |
Aciphex Eisai Inc. |
213,378 |
-1.07% |
Stats |
74 ( 2) |
Orencia Bristol-Myers Squibb Company |
211,272 |
3.89% |
Stats |
75 ( 5) |
Dexilant Takeda Pharmaceutical Company Limited |
210,175 |
5.01% |
Stats |
76 ( 5) |
Aranesp Amgen Inc. |
210,027 |
-4.44% |
Stats |
77 ( 2) |
VESIcare Astellas Pharma US, Inc. |
209,122 |
3.76% |
Stats |
78 ( ) |
fenofibrate Generic |
206,565 |
n/a |
Stats |
79 ( 4) |
Pradaxa Boehringer Ingelheim Pharmaceuticals, Inc. |
205,238 |
-1.83% |
Stats |
80 ( 14) |
Prevnar 13 Pfizer Inc. |
204,585 |
15.24% |
Stats |
81 |
Adderall XR Takeda Pharmaceutical Company Limited |
202,948 |
2.53% |
Stats |
82 ( 5) |
Betaseron Bayer HealthCare Pharmaceuticals Inc. |
202,032 |
-0.56% |
Stats |
83 ( 9) |
Renvela Sanofi |
201,365 |
9.62% |
Stats |
84 ( 15) |
atorvastatin Generic |
196,153 |
15.04% |
Stats |
85 ( 3) |
fentanyl Generic |
194,261 |
-1.28% |
Stats |
86 |
Benicar Daiichi Sankyo |
193,275 |
2.27% |
Stats |
87 ( 6) |
Lunesta Sunovion Pharmaceuticals Inc. |
192,034 |
4.83% |
Stats |
88 ( 2) |
Synthroid AbbVie Inc. |
190,754 |
2.63% |
Stats |
89 ( 4) |
Evista
|
189,910 |
0.28% |
Stats |
90 ( ) |
Ventolin HFA GlaxoSmithKline |
186,276 |
n/a |
Stats |
91 |
Xolair
|
182,829 |
-0.81% |
Stats |
92 ( 5) |
Sensipar Amgen Inc. |
182,611 |
5.97% |
Stats |
93 ( 7) |
Stelara Janssen Pharmaceuticals, Inc. |
182,409 |
7.52% |
Stats |
94 ( 53) |
TriCor AbbVie Inc. |
180,903 |
-41.58% |
Stats |
95 |
Xeloda Genentech, Inc. |
178,469 |
1.16% |
Stats |
96 ( ) |
Xgeva Amgen Inc. |
173,788 |
n/a |
Stats |
97 ( 1) |
Zyvox Pfizer Inc. |
169,211 |
-1.48% |
Stats |
98 ( ) |
Focalin XR Novartis Pharmaceuticals Corporation |
168,218 |
n/a |
Stats |
99 ( ) |
pioglitazone Generic |
165,901 |
n/a |
Stats |
100 ( ) |
Sandostatin LAR Depot Novartis Pharmaceuticals Corporation |
162,139 |
n/a |
Stats |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.